Consolidated Statement of Cash Flows	6 Months Ended
	Dec. 31, 2020 USD ($)
Statement of Cash Flows [Abstract]
Net loss	$ (38,913,797)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(90,128)
Change in fair value of warrant liability	36,786,664
Offering costs allocated to warrant liability	1,015,795
Unrealized gain on marketable securities held in Trust Account	(8,084)
Changes in operating assets and liabilities:
Prepaid expenses	(638,013)
Accrued expenses	753,547
Net cash used in operating activities	(1,094,016)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(460,000,000)
Net cash used in investing activities	(460,000,000)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from sale of Units, net of underwriting discounts paid	450,800,000
Proceeds from sale of Private Placement Warrants	14,000,000
Advances from related party	229,886
Repayment of advances from related party	(229,886)
Proceeds from promissory note – related party	261,386
Repayment of promissory note – related party	(261,386)
Payment of offering costs	(465,909)
Net cash provided by financing activities	464,359,091
Net Change in Cash	3,265,075
Cash - Beginning of period
Cash - End of period	3,265,075
Non-Cash investing and financing activities:
Initial classification of Class A common stock subject to possible redemption	414,384,970
Change in value of Class A common stock subject to possible redemption	(37,895,840)
Initial classification of warrant liability	28,860,000
Deferred underwriting fee payable	16,100,000
Offering costs included in accrued offering costs	$ 11,950